KRAS mutations located in codon 12 and codon 13 of exon 26 are among the most frequently detected activating mutations in human cancers, being present in 65% to 100% of pancreatic cancer and 30% to 50% of colorectal cancer cases. This evidence concerns the gene KRAS and cancer.